← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. WAT
  3. P/E History
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets

WAT logoWaters Corporation (WAT) P/E Ratio History

Historical price-to-earnings valuation from 1996 to 2026

Current P/E
32.5
Fair Value
5Y Avg P/E
30.5
+6% vs avg
PE Percentile
60%
Above Avg
PEG Ratio
6.27
Expensive
TTM EPS$5.47
Price$349.53
5Y PE Range23.5 - 38.7
Earnings Yield3.08%

Loading P/E history...

WAT Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
32.5vs30.5
+6%
In Line with History
vs. Healthcare
32.5vs22.1
+47%
Above Sector
vs. S&P 500
32.5vs25.2
+29%
Above Market
PEG Analysis
6.27
P/E ÷ EPS Growth
PEG > 2 = Expensive
Based on 0% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 6, 2026, Waters Corporation (WAT) trades at a price-to-earnings ratio of 32.5x, with a stock price of $349.53 and trailing twelve-month earnings per share of $5.47.

The current P/E is roughly in line with its 5-year average of 30.5x. Over the past five years, WAT's P/E has ranged from a low of 23.5x to a high of 38.7x, placing the current valuation at the 60th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, WAT trades at a 47% premium to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.

The PEG ratio of 6.27 (P/E divided by 0% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.

Relative to the broader market, WAT commands a significant premium over the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our WAT DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

WAT P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
A logoAAgilent Technologies, Inc.
$33B25.8Lowest1.75Best+3%
TMO logoTMOThermo Fisher Scientific Inc.
$176B26.712.62+7%
DHR logoDHRDanaher Corporation
$124B34.7--5%
RGEN logoRGENRepligen Corporation
$7B146.2-+287%Best
FELE logoFELEFranklin Electric Co., Inc.
$4B31.13.56-16%
IDXX logoIDXXIDEXX Laboratories, Inc.
$46B44.33.10+23%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

WAT Historical P/E Data (1996–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2026 Q1Sat Apr 04 2026 00:00:00 GM$304.24$7.8738.7x-18%
FY2025 Q4Wed Dec 31 2025 00:00:00 GM$379.83$10.7735.3x-26%
FY2025 Q3Sat Sep 27 2025 00:00:00 GM$291.71$10.8826.8x-43%
FY2025 Q2Sat Jun 28 2025 00:00:00 GM$352.41$11.0931.8x-33%
FY2025 Q1Sat Mar 29 2025 00:00:00 GM$362.16$11.0232.9x-31%
FY2024 Q4$370.98$10.7134.6x-27%
FY2024 Q3Sat Sep 28 2024 00:00:00 GM$357.33$10.4834.1x-28%
FY2024 Q2Sat Jun 29 2024 00:00:00 GM$290.12$10.0428.9x-39%
FY2024 Q1Sat Mar 30 2024 00:00:00 GM$344.23$10.1933.8x-29%
FY2023 Q4Sun Dec 31 2023 00:00:00 GM$329.23$10.8530.3x-36%
FY2023 Q3Sat Sep 30 2023 00:00:00 GM$274.21$11.0124.9x-47%
FY2023 Q2Sat Jul 01 2023 00:00:00 GM$266.54$11.3423.5x-50%

Average P/E for displayed period: 47.4x

Full WAT Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

See WAT's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is WAT Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare WAT vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

WAT — Frequently Asked Questions

Quick answers to the most common questions about buying WAT stock.

Is WAT stock overvalued or undervalued?

WAT trades at 32.5x P/E, near its 5-year average of 30.5x. The 60th percentile ranking places valuation within normal historical bounds.

How does WAT's valuation compare to peers?

Waters Corporation P/E of 32.5x compares to sector median of 22.1x. The premium reflects expected growth above peers.

What is WAT's PEG ratio?

WAT PEG ratio is 6.27. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1996-2026.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

WAT P/E Ratio History (1996–2026)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.